Orthofix Medical (OFIX) Liabilities and Shareholders Equity (2016 - 2025)
Orthofix Medical's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $850.6 million for Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 4.77% year-over-year to $850.6 million, compared with a TTM value of $3.3 billion through Dec 2025, down 5.79%, and an annual FY2025 reading of $850.6 million, down 4.77% over the prior year.
- Liabilities and Shareholders Equity for Q4 2025 was $850.6 million at Orthofix Medical, up from $832.6 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $925.3 million in Q4 2023, with the low at $449.7 million in Q3 2022.
- Average Liabilities and Shareholders Equity over 5 years is $718.4 million, with a median of $834.9 million recorded in 2025.
- Year-over-year, Liabilities and Shareholders Equity decreased 15.73% in 2021 and then surged 101.76% in 2023.
- Tracing OFIX's Liabilities and Shareholders Equity over 5 years: stood at $476.6 million in 2021, then dropped by 3.78% to $458.6 million in 2022, then surged by 101.76% to $925.3 million in 2023, then fell by 3.46% to $893.3 million in 2024, then dropped by 4.77% to $850.6 million in 2025.
- Per Business Quant, the three most recent readings for OFIX's Liabilities and Shareholders Equity are $850.6 million (Q4 2025), $832.6 million (Q3 2025), and $837.2 million (Q2 2025).